157 -3 (31/4) 2020 — Khamidov F.SH., Fozilov E.A. — THERAPY OF PSORIASIS IN THE NEW CEBTURY

THERAPY OF PSORIASIS IN THE NEW CENTURY

Khamidov F.Sh. -Andijan State Medical Institute.

Fozilov ЕА. -Andijan State Medical Institute.

Mominov M.M. -Andijan State Medical Institute.

Abdurahmonov A.A. -Andijan State Medical Institute.

Resume

The authors provide data on new drugs and treatment methods (traditional systemic drugs, herbal medicine, treatment with photoactive substances – PUVA, targeted drugs, genetically engineered biological drugs (GEBD), synthetic targeted drugs, small molecules) of psoriasis.

Key words: psoriasis, traditional systemic drugs, herbal medicine, treatment with photoactive substances – PUVA, targeted drugs, genetically engineered biological drugs, GEBD, synthetic targeted agents, small molecules, therapy, treatment.

First page

642

Last page

644

For citation: Khamidov F.Sh., Fozilov ЕА., Mominov M.M., Abdurahmonov A.A., Therapy of psoriasis in the new century//Naw Day in Medicine 3(31)2020 642-644 https://cutt.ly/XxLwNGs

List of References

  1. Государственный реестр лекарственные средств. Инструкция по чедицинскочу применению секукинумаба // URL: http:// grls.rosminzdrav.ru/grls.aspx.
  2. Государственный реестр лекарственные средств. Инструкция по медицинкому применению цик.лоспорина, метотрексата, ацитретина. [Электронный ресурс] // URL: http:// grls.rosminzdrav.ru/grls.aspx.
  3. Федеральные клинические рекомевдации по ведению боль- шгх псориазом. – М., 2015. Abuabara K, et al. Br J Dermatol, 2010. 163:586-592.
  4. Archier, E., Devaux, S., Castela, E., Gallini, A., Aubin, F., Le Ma?tre, M., Aractingi, S., 5.Bachelez, H., Cribier, B., Joly, P., Jullien, D., Misery, L., Paul, C., Ortonne, J.-P. and Richard, M.-A. (2012), Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. Journal of the European Academy of Dermatology and Venereology, 26: 22-31. DOI:10.1111/j.1468-3083.2012.04520.x.
  5. Armstrong EJ, et al. J Am Heart Assoc, 2013. 2:e000062.
  6. Busse K, et al. Psoriasis Forum, 2010. 16:17-25.
  7. Carretero Hern?ndez G. et al. Descripci?n de los pacientes que reciben biol?gicos como primer tratamiento sist?mico en el registro BIOBADADERM durante el periodo 2008-2016. Actas Dermosifiliogr, 2018.
  8. Christphers E, Griffiths CE, Gaitanis G, van de Kerkhof P. The unmet treatment need for moderate to severe psoriasis: results of a survey and chart review. J Eur Acad Dermatol Venereol, 2006. 20:921-5.
  9. Fraga NA de A et al. Anais brasileiros de dermatologia. 2012;87(6):877-883. DOI:10.1590/S0365-05962012000600009.
  10. Gelfand et al. Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice Setting Arch Dermatol, 2012 April. 148(4): 487-494. DOI:10.1001/archdermatol.2012.370.
  11. Gelfand JM, et al. Arch Dermatol, 2007. 143:1493-1499.
  12. Langan SM, Seminara NM, Shin DB, et al. Journal of investigative dermatology, 2012. 132(3 0 1):556-562. DOI:10.1038/jid.2011.365.
  13. Levin EC, Gupta R, Brown G, Malakouti M, Koo J. Biologic fatigue in psoriasis. J Dermatolog Treat, 2014. 25:78-82.
  14. Prey S, et al. J Eur Acad Dermatol Venereol, 2010. 24(suppl 2):31-35.
  15. Rapp, Stephen R. et al. Psoriasis causes as much disability as other major medical diseases. Journal of the American Academy of Dermatology, vol. 41 , i. 3, pp. 401-407.
  16. Svedbom A, Dal?n J, Mamolo C, Cappelleri JC, Petersson IF, St?hle M. Treatment patterns with topicals, traditional systemics and biologics in psoriasis – a Swedish database analysis. J Eur Acad Dermatol Venereol, 2015. 29:215-23.
  17. Therezia Bokor-Billmann & Knut Sch?kel. No need to change the drug class: ixekizumab- following secukinumab-therapy in psoriasis. Journal of Dermatological Treatment. ISSN: 0954-6634 (Print) 1471-1753 (Online).
  18. Van Vollenhoven RF. Switching between anti-tumour necrosis factors: trying to get a handle on a complex issue. Ann Rheum Dis, 2007. 66:849-51.
  19. Yeung H, Takeshita J, Mehta NN, Kimmel SE, Ogdie A, Margolis DJ, Shin DB, Attor R, Troxel AB, Gelfand JM. Psoriasis severity and the prevalence of major medical comorbidity: a population­based study. JAMA Dermatol. 2013 Oct; 149(10):1173-9.
157-642-644-3-31-2020-

file

download